Impel Pharmaceuticals

Quick facts

Marketed products

• Zydis · Other

Phase 1 pipeline

• Zyprexa IM

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Impel Pharmaceuticals portfolio CI brief
• Impel Pharmaceuticals pipeline updates RSS